CAR-T Meeting 2020 | CAR T-cell therapy access and reimbursement: the patient’s perspective
Bregje Verhoeven
• 30 Jan 2020
Bregje Verhoeven, European Society for Blood & Marrow Transplantation (EBMT), Leiden, The Netherlands, discusses the access and reimbursement of CAR T-cell therapy, it’s importance and the patients’ perspective of CAR T-cell therapy regulation. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.
